Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature.
Agrawal
D
D
Dallas VA Medical Center and University of Texas Southwestern Medical Center, Dallas, TX, USA.
Patterson
T F
TF
University of Texas Health Science Center at San Antonio, TX, USA.
Rinaldi
M G
MG
University of Texas Health Science Center at San Antonio, TX, USA.
Revankar
S G
SG
Harper University Hospital, Wayne State University, 3990 John R. St., 5 Hudson, Detroit, MI 48201, USA.
D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000145:classification / Q000187:drug effects / Q000254:growth & development; D015725:Fluconazole / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards; D008828:Microbiological Techniques; D010641:Phenotype; D013696:Temperature
D000935:Antifungal Agents; D015725:Fluconazole